Skip to main content
Year archive

BIOXYNE LIMITED — 2023 filings

All 40 regulatory filings released by BIOXYNE LIMITED (BXN) in 2023, sourced directly from the official regulator.

40 Filings
2023 Period
2023 filings (40)
Filing Released Lang
Annual General Meeting Presentation 10 pages 8.1MB
Regulatory Filings
2023-11-16 English
Results of Meeting 2 pages 605.5KB
Regulatory Filings
2023-11-16 English
Retirement of Director 1 page 585.7KB
Regulatory Filings
2023-11-16 English
Final Director's Interest Notice 2 pages 157.2KB
Regulatory Filings
2023-11-16 English
Change in substantial holding 2 pages 160.3KB
Regulatory Filings
2023-11-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 946.0KB
Regulatory Filings
2023-10-30 English
BLS Builds Medicinal Business In Australia 2 pages 640.0KB
Regulatory Filings
2023-10-18 English
Notice of Annual General Meeting/Proxy Form 26 pages 532.3KB
Regulatory Filings
2023-10-17 English
Letter to Shareholders re Annual General Meeting Notice 1
Regulatory Filings
2023-10-17 English
Change of Director's Interest Notice 2 pages 232.6KB
Regulatory Filings
2023-10-16 English
Change of Director's Interest Notice 2 pages 193.0KB
Regulatory Filings
2023-10-08 English
AGM Date 2023 and Closing Date for Director Nominations 1
Regulatory Filings
2023-10-04 English
Appendix 4G and Corporate Governance Statement 29 pages 733.9KB
Regulatory Filings
2023-09-28 English
Annual Report to shareholders 54 pages 2.4MB
Regulatory Filings
2023-09-28 English
Preliminary Final Report 35 pages 1.1MB
Regulatory Filings
2023-08-30 English
Bioxyne Signs Joint Venture with CanXChange 2 pages 611.1KB
Regulatory Filings
2023-08-14 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 954.3KB
Regulatory Filings
2023-07-30 English
BLS Extends Amazon Footprint into US and Japan 2 pages 658.5KB
Regulatory Filings
2023-07-16 English
Bioxyne Launches BLS Clinics - Online Healthcare 2 pages 654.8KB
Regulatory Filings
2023-06-12 English
Becoming a substantial holder 2 pages 208.3KB
Regulatory Filings
2023-06-07 English
Change in substantial holding 3 pages 471.5KB
Regulatory Filings
2023-05-30 English
Becoming a substantial holder 3 pages 1.3MB
Regulatory Filings
2023-05-30 English
Notification regarding unquoted securities - BXN 7 pages 31.4KB
Regulatory Filings
2023-05-24 English
Initial Directors Interest Notice X 2 4 pages 166.9KB
Regulatory Filings
2023-05-22 English
Final Directors Interest Notice X 2 4 pages 182.3KB
Regulatory Filings
2023-05-22 English
Becoming a substantial holder 358 pages 18.9MB
Regulatory Filings
2023-05-22 English
Becoming a substantial holder 3 pages 284.8KB
Regulatory Filings
2023-05-22 English
Ceasing to be a substantial holder X 2 2 pages 4.3MB
Regulatory Filings
2023-05-22 English
Bioxyne Completes Acquisition of Breathe Life Sciences 4 pages 768.6KB
Regulatory Filings
2023-05-21 English
Application for quotation of securities - BXN 6 pages 30.2KB
Regulatory Filings
2023-05-21 English
Application for quotation of securities - BXN 6 pages 30.2KB
Regulatory Filings
2023-05-21 English
Cleansing Notice 1 page 547.3KB
Regulatory Filings
2023-05-21 English
Results of Meeting 3 pages 153.6KB
Regulatory Filings
2023-05-04 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 265.0KB
Regulatory Filings
2023-04-23 English
Notice of Meeting Proxy Form Independent Experts Report 142 pages 2.8MB
Regulatory Filings
2023-04-05 English
Letter to Shareholders re Notice of Meeting 1 page
Regulatory Filings
2023-04-05 English
Bioxyne Executes SPA to Acquire Breathe Life Sciences 4 pages 243.4KB
Regulatory Filings
2023-03-19 English
Becoming a substantial holder 2 pages 139.3KB
Regulatory Filings
2023-02-26 English
Half Yearly Report and Accounts 21 pages 768.4KB
Regulatory Filings
2023-02-22 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 273.6KB
Regulatory Filings
2023-01-26 English